Sentence examples for comparing firms from inspiring English sources

Roger Smeets of Rutgers looked at R&D spending by small firms, comparing firms that were hit by extensive lawsuits to a carefully chosen comparable sample.

We infer the causal effects of patent allowances by comparing firms whose patent applications were initially allowed to those whose patent applications were initially rejected.

By comparing firms that are foreign-owned, and therefore have access to other forms of financing, with those that are domestic, and so rely on local banks, the authors can see what uncertainty about financial access did to their decision-making after the 2008 crisis.

For example, according to 2007 Census data, comparing firms with under half a million in sales to those with over $100 million, the small firms averaged 15 employees per $100 million sales while the big ones averaged only three.

In 2007, comparing firms with under half a million in sales to those with over $100 million, the small firms averaged 15 employees per $100 million sales while the big ones averaged only three.

This is useful for comparing firms in the same industry to determine which are most profitable.[17].[17]

Clinically, adding FIRM to conventional ablation substantially improves arrhythmia freedom compared with conventional ablation alone, and ongoing randomized trials are comparing FIRM-ablation with and without conventional ablation to conventional ablation alone.

By comparing firm 2's profits for the two candidates, we obtain: (6).

Secondly, kinematic variables that were significantly different between firm surface take-offs and compliant surface take-offs at 1.8 m were then investigated for the conditions representing 1.2 m jumps, again comparing firm surface take-offs with compliant surface take-offs.

In both cases, we examine the set of firms expected to disclose (or that actually disclosed) and compare firms that were expected to disclose that they paid no tax (or that actually disclosed that they paid no tax), and find negative market reactions for these firms, compared with firms that paid tax.

What makes our study unique is that we compared firms' innovation activities not only before and after acquisitions, but we also compared those merging companies to firms in similar pharmaceutical markets without merger activities.